Kazuhide Takata

14PUBLICATIONS
10CO-AUTHORS
Metabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 29, 2025
Identification and Characterization of Three Novel Biomarkers for Mixed/Cholestatic Drug-Induced Liver Injury.

Kosuke Saito, Tatehiro Kagawa, Keiji Tsuji

|Dec 10, 2022
Complete tumor necrosis confirmed by conversion hepatectomy after atezolizumab-bevacizumab treatment for advanced-stage hepatocellular carcinoma with lung metastasis.

Atsushi Fukunaga, Kazuhide Takata, Shinji Itoh

|Sep 23, 2022
Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites.

Keiji Yokoyama, Hiromi Fukuda, Ryo Yamauchi

|Jul 25, 2022
Pretreatment Modified Albumin-Bilirubin Grade Is an Important Predictive Factor Associated with the Therapeutic Response and the Continuation of Atezolizumab plus Bevacizumab Combination Therapy for Patients with Unresectable Hepatocellular Carcinoma.

Takashi Tanaka, Kazuhide Takata, Keiji Yokoyama

|Dec 09, 2021
Multiple focal fatty changes in the liver in patients with porphyria cutanea tarda: A case series and review of the literature.

Kazuhide Takata, Atsushi Fukunaga, Shinya Nishizawa

|Dec 28, 2020
Hepatitis B virus core-related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: Case report.

Keiji Yokoyama, Eri Yamauchi, Yotaro Uchida

Pageof 3

Frequent Collaborators

3 joint publications

Fumihito Hirai

3 joint publications

Keiji Yokoyama

3 joint publications

Ryo Yamauchi

2 joint publications

Takashi Tanaka